Magnus Olafsson Corfitzen

Magnus Olafsson Corfitzen

Chief Executive Officer presso ASCELIA PHARMA AB

Patrimonio netto: 275 323 $ in data 31/03/2024

49 anni
Health Technology
Finance
Commercial Services

Profilo

Mr. Magnus Olafsson Corfitzen is a Chief Executive Officer at Ascelia Pharma AB.
He is on the Board of Directors at Ascelia Incentive AB and Inventive AB.
Mr. Corfitzen was previously employed as an Investment Director by Sunstone Capital A/S, a Chief Executive Officer by CMC Contrast AB, an Investment Director by Danmarks Eksport- og Investeringsfond, a Portfolio Manager by Danske Bank A/S (Investment Management), a Portfolio Manager by Danske Capital AB, a Chairman by FBC Device ApS, a Principal by McKinsey & Co., Inc., and a Chief Executive Officer by Oncoral Pharma ApS.
He also served on the board at Vivostat A/S, Aro Medical ApS, DentoFit A/S, Nordic Vaccine A/S and Opsona Therapeutics Ltd.
He received his graduate degree from the University of Aarhus.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
17/07/2023 319 645 ( 0.95% ) 275 323 $ 31/03/2024

Posizioni attive di Magnus Olafsson Corfitzen

SocietàPosizioneInizio
ASCELIA PHARMA AB Chief Executive Officer 01/01/2014
Inventive AB Director/Board Member -
Ascelia Incentive AB Director/Board Member -
Tutte le posizioni attive di Magnus Olafsson Corfitzen

Precedenti posizioni note di Magnus Olafsson Corfitzen

SocietàPosizioneFine
Director of Investments 30/06/2014
Director/Board Member 27/01/2014
Chief Executive Officer -
Corporate Officer/Principal -
Corporate Officer/Principal -
Vedi nel dettaglio l'esperienza di Magnus Olafsson Corfitzen

Formazione di Magnus Olafsson Corfitzen

University of Aarhus Graduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Magnus Olafsson Corfitzen

Relazioni

63

Relazioni di 1° grado

17

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa1
ASCELIA PHARMA AB

Health Technology

Aziende private15

Health Technology

Commercial Services

Finance

Finance

Finance

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Ascelia Incentive AB

Inventive AB

Vedi le connessioni aziendali
  1. Borsa valori
  2. Insiders
  3. Magnus Olafsson Corfitzen